Particle size and stability: the smaller and more uniform the liposomes, the better they are generally absorbed, and the more stable the formulation remains until the moment of ingestion
Since GLP-1s are increasingly used as chronic therapies, 3 this long-term model must support continuous production rather than episodic scaling to help meet this need
(Contains: Semaglutide) ** For 1st time users we recommend (0.25mg/week) dosing
Phase 3 studies are currently underway
During 2024 and 2025, the GLP-1 class was increasingly defined by expanded use cases and approvals, with existing drugs gaining indications including cardiovascular risk, sleep apnea and kidney disease
Pharmacologic GLP-1 RAs are synthetic analogs designed to resist degradation by dipeptidyl peptidase-4 (DPP-4), thereby prolonging their half-life